Viewing Study NCT00782067

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:45 AM
Ignite Modification Date: 2026-02-20 @ 10:12 PM
Study NCT ID: NCT00782067
Status: COMPLETED
Last Update Posted: 2018-11-15
First Post: 2008-10-28
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Aggressive systemic mastocytosis View
None mast cell leukemia View
None C-Findings View
None tyrosine kinase inhibitor View
None KIT mutation View
None AHNMD View
None Systemic View
None Aggressive View